Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling
Dan A. Dixon, Neal D. Tolley, Kristi Bemis-Standoli, Mark L. Martinez, Andrew S. Weyrich, Jason D. Morrow, Stephen M. Prescott, Guy A. Zimmerman
Dan A. Dixon, Neal D. Tolley, Kristi Bemis-Standoli, Mark L. Martinez, Andrew S. Weyrich, Jason D. Morrow, Stephen M. Prescott, Guy A. Zimmerman
View: Text | PDF
Research Article Inflammation

Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling

  • Text
  • PDF
Abstract

Tight regulation of COX-2 expression is a key feature controlling eicosanoid production in atherosclerosis and other inflammatory syndromes. Adhesive interactions between platelets and monocytes occur in these conditions and deliver specific signals that trigger inflammatory gene expression. Using a cellular model of monocyte signaling induced by activated human platelets, we identified the central posttranscriptional mechanisms that regulate timing and magnitude of COX-2 expression. Tethering of monocytes to platelets and to purified P-selectin, a key adhesion molecule displayed by activated platelets, induces NF-κB activation and COX-2 promoter activity. Nevertheless, COX-2 mRNA is rapidly degraded, leading to aborted protein synthesis. Time-dependent signaling of monocytes induces a second phase of transcript accumulation accompanied by COX-2 enzyme synthesis and eicosanoid production. Here, generation of IL-1β, a proinflammatory cytokine, promoted stabilization of COX-2 mRNA by silencing of the AU-rich mRNA decay element (ARE) in the 3′-untranslated region (3'UTR) of the mRNA. Consistent with observed mRNA stabilization, activated platelets or IL-1β treatment induced cytoplasmic accumulation and enhanced ARE binding of the mRNA stability factor HuR in monocytes. These findings demonstrate that activated platelets induce COX-2 synthesis in monocytes by combinatorial signaling to transcriptional and posttranscriptional checkpoints. These checkpoints may be altered in disease and therefore useful as targets for antiinflammatory intervention.

Authors

Dan A. Dixon, Neal D. Tolley, Kristi Bemis-Standoli, Mark L. Martinez, Andrew S. Weyrich, Jason D. Morrow, Stephen M. Prescott, Guy A. Zimmerman

×

Figure 8

IL-1β regulates COX-2 mRNA decay through the ARE-binding protein HuR.

Options: View larger image (or click on image) Download as PowerPoint
IL-1β regulates COX-2 mRNA decay through the ARE-binding protein HuR.
(A...
(A) LUC/3'UTR-reporter constructs containing no 3'UTR (LUCΔ3'UTR, white bars) or COX-2 3'UTR (LUC+3'UTR, black bars) were transfected into U937 cells. LUC activity (RLU) was normalized to total protein and is the average of 3 experiments. (B) U937 cells were transfected with LUC/3'UTR reporter constructs and kept in suspension medium (co), incubated on immobilized P-selectin, kept in suspension in medium containing 10 ng/ml IL-1β, or incubated on immobilized P-selectin in medium containing IL-1β. Relative LUC activity was normalized to total protein, and values shown are based on LUC expression from control transfections. (C) U937 cells (106 cells) were left untreated (co) or incubated for 18 hours with 10 ng/ml IL-1β. ARE-binding proteins HuR and TIA-1 were examined in 15 μg of total cell lysates and 25 μg of cytoplasmic lysates by immunoblot. β-actin was detected as a loading control. (D) Cytoplasmic lysates from untreated (co) or IL-1β–treated U937 cells were incubated with 32P-labeled AREs based on COX-2 or GM-CSF mRNA sequences. Bound proteins were cross-linked to the ARE and immunoprecipitated, using anti-HuR Ab or control IgG. The arrowhead indicates the major immunoprecipitated species. (E) Platelets were incubated with monocytes for 1 hour and 18 hours in the presence of thrombin, then examined for HuR localization by immunocytochemical analysis. Immunofluorescence of HuR in platelet-monocyte aggregates is shown in green; platelet and monocyte cytoskeleton are shown in red. Thick arrows indicate monocyte nuclei; thin arrow indicates monocyte cytoplasm. Scale bar: 5 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts